Source: Biomedical Reports. Unidade: FMRP
Subjects: ANSIEDADE, DEPRESSÃO, NEOPLASIAS COLORRETAIS
ABNT
MIRANDA, Diego Oliveira et al. Fractalkine (C‑X3‑C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients. Biomedical Reports, n. 2, p. 188-192, 2017Tradução . . Disponível em: https://doi.org/10.3892/br.2017.937. Acesso em: 05 out. 2024.APA
Miranda, D. O., Anatriello, E., Azevedo, L. R., Santos, J. C. dos, Cordeiro, J. F. C., Peria, F. M., et al. (2017). Fractalkine (C‑X3‑C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients. Biomedical Reports, ( 2), 188-192. doi:10.3892/br.2017.937NLM
Miranda DO, Anatriello E, Azevedo LR, Santos JC dos, Cordeiro JFC, Peria FM, Santos MJSFL, Bisson GS. Fractalkine (C‑X3‑C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients [Internet]. Biomedical Reports. 2017 ;( 2): 188-192.[citado 2024 out. 05 ] Available from: https://doi.org/10.3892/br.2017.937Vancouver
Miranda DO, Anatriello E, Azevedo LR, Santos JC dos, Cordeiro JFC, Peria FM, Santos MJSFL, Bisson GS. Fractalkine (C‑X3‑C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients [Internet]. Biomedical Reports. 2017 ;( 2): 188-192.[citado 2024 out. 05 ] Available from: https://doi.org/10.3892/br.2017.937